Sprunglinks

News

You are here: / / / Affinity and receptor expression limits tested for LRC-TriCEPS

Affinity and receptor expression limits tested for LRC-TriCEPS

Dualsystems Biotech AG is testing the limits of the LRC-TriCEPSTM (CaptiRec) technology using antibodies with different affinities against the same target and cells expressing the target receptor with different expression levels.

Limits-of-LRC-TriCEPS

Limits-of-LRC-TriCEPS

Details of the assesment see here

You might also like
Biaffin-anti-EGFRDualsystems Biotech AG and Biaffin GmbH & Co KG perform together an example of an experiment
Dualystems Biotech Video how the LRC-TriCEPS technology worksDualsystems Biotech sells its yeast two-hybrid (Y2H) activities to Hybrigenics
Dualystems Biotech Video how the LRC-TriCEPS technology worksDualsystems Biotech partners with IBR Inc. to validate the workflow of the CaptiRec Technology
Vulcano-Plot-on-protein-level-2018CaptiREC (LRC-TriCEPS) experiment performed at Dualsystems
Dualystems Biotech Video how the LRC-TriCEPS technology worksVideo – how the LRC-TriCEPS technology works
Dualystems Biotech Video how the LRC-TriCEPS technology worksDualsystems closes Series C Financing Round
BIO-Europe Spring® Conference in Paris/France 2015, March 9-11Bio Europe Spring 15- LogoAre research antibodies reliable?
DO YOU WANT TO TEST IT NOW?
Transport not incl. Your Information will never be shared with any third party.
To get pretest TriCEPS Material please contact us!

Identify the targets of your ligand on the living cells. Prior to the main experiment get free TriCEPS Material to test the functionality of your TriCEPS coupled ligand.
  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Engineered affinity binders
  • Viruses
DO YOU WANT TO TALK TO US?
Your information will never be shared with any third party.
LRC-TriCEPS to identify targets on the surface of living cells.

Please provide your email address and we will contact you to arrange a call.
  • Small molecules
  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Engineered affinity binders
  • Viruses